Golden Green’s Allena Pharmaceuticals ALNA Stock Holding History

Golden Green’s Portfolio ALNA Stock Details ALNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-25,000	Closed	-$5K	–	80
2022 Q2	$5K	Hold	25,000	–	–	0.01%	65
2022 Q1	$6K	Hold	25,000	–	–	﹤0.01%	80
2021 Q4	$15K	Sell	25,000 -8,000	-24%	-$6.25K	0.01%	119
2021 Q3	$30K	Buy	33,000 +12,000	+57%	+$11.7K	0.02%	144
2021 Q2	$27K	Sell	21,000 -8,000	-28%	-$9.69K	0.02%	153
2021 Q1	$40K	Sell	29,000 -10,000	-26%	-$16.7K	0.03%	166
2020 Q4	$50K	Buy	+39,000	New	+$54.4K	0.05%	123

Other funds holding ALNA

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Golden Green's ALNA Position: Q3 2022 in Review

Golden Green sold out of Allena Pharmaceuticals (ALNA) in Q3 2022, closing a stake of 25,000 shares — an estimated $5K sold.

Golden Green first reported a position in ALNA in Q4 2020 and held it in 7 quarters. The position peaked at $50K in Q4 2020. 2 funds tracked by Wall St. Rank hold ALNA as of Q3 2022.

Golden Green reported no remaining Allena Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
Golden Green sold 25,000 Allena Pharmaceuticals shares in Q3 2022, an estimated $5K.
Golden Green first reported a position in Allena Pharmaceuticals in Q4 2020 and held it in 7 quarters.
Golden Green's Allena Pharmaceuticals position peaked at $50K in Q4 2020.
2 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q3 2022.

Based on Golden Green's 13F filing for Q3 2022, filed 14 Oct 2022.